轻度创伤性脑损伤作为帕金森症,提克症和阿卡西西亚的危险因素:系统性审查和元分析
Nashaba Khan1, Laura Romila2, Alin Ciobica3
1Department of Neurosciences, Leeds Teaching Hospitals, NHS Trust, Leeds LS97TF, UK.
Life (Basel, Switzerland)
|January 23, 2024
概括
轻度创伤性脑损伤 (mTBI) 显著增加患帕金森症的风险,包括帕金森病 (PD). 这一发现是基于对18项涉及超过140万参与者的研究的元分析.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 流行病学 流行病学
背景情况:
- 轻度创伤性脑损伤 (mTBI) 是一种常见的损伤,具有潜在的长期神经后果.
- 帕金森症,一种以运动障碍为特征的综合征,包括帕金森病 (PD) 作为其最常见的形式.
- mTBI与随后患帕金森症的风险之间的关系仍然是积极研究的领域.
研究的目的:
- 进行一项元分析,评估轻度创伤性脑损伤 (mTBI) 史与患帕金森症的风险之间的关联.
- 为了量化帕金森症的风险,特别是帕金森病 (PD) 后的mTBI.
主要方法:
- 使用主要数据库 (PubMed,Embase,Cochrane图书馆) 进行了系统的文献审查.
- 包括报告mTBI和帕金森症的符合条件的研究.
- 使用随机效应模型计算了聚合赔率比率 (OR),并评估了出版偏差.
主要成果:
- 分析包括了18项研究,其中有1,484,752名参与者.
- 患有mTBI的病史与帕金森症的风险显著增加有关 (OR = 1.637,p=0.01).
- 发展帕金森病 (PD) 的风险也特别高 (OR = 1.717,p=0.01).
结论:
- 轻度创伤性脑损伤 (mTBI) 被认为是帕金森症,特别是帕金森病 (PD) 的重要危险因素.
- 虽然这种关联在统计学上是显著的,但由于研究异质性和局限性,研究结果应谨慎解释.
- 需要进一步的研究来阐明连接mTBI和帕金森症的潜在机制.
相关概念视频
Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551


